Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 145.50
-4.50 (-3.00%)
At close: May 29, 2026
Bonraybio Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 102.36 | 102.51 | 68.37 | 25.73 | 1.69 | -31.71 |
Depreciation & Amortization | 12.63 | 12.26 | 11.15 | 10.64 | 9.37 | 11.15 |
Other Amortization | 1.18 | 1.18 | 0.68 | - | 0.14 | 0.1 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.42 |
Stock-Based Compensation | - | - | 0.03 | - | 0.08 | 0.52 |
Other Operating Activities | 5.68 | 0.9 | -2.95 | -0.47 | -0.68 | -3.43 |
Change in Accounts Receivable | -6.7 | -6.2 | -5.14 | -9.36 | -0.1 | -3.85 |
Change in Inventory | -12.32 | -15.82 | -8.33 | -2.59 | -2.88 | -0.89 |
Change in Accounts Payable | -3.62 | -2.16 | 1.49 | -0.1 | 0.2 | 2.13 |
Change in Unearned Revenue | -1.44 | 0.92 | 4.13 | -0.52 | 1.58 | -0.14 |
Change in Other Net Operating Assets | 16.05 | 6.41 | 10.72 | 3.57 | 2.59 | 0.61 |
Operating Cash Flow | 113.83 | 99.99 | 80.14 | 26.9 | 11.98 | -25.09 |
Operating Cash Flow Growth | 66.11% | 24.78% | 197.95% | 124.50% | - | - |
Capital Expenditures | -16.46 | -18.57 | -2.17 | -5.63 | -4.08 | -2.96 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0 |
Sale (Purchase) of Intangibles | -13.17 | -15.67 | -8.85 | -4.12 | -3.87 | -1.68 |
Investment in Securities | -38 | -184.4 | - | 9.8 | 4.14 | -73.44 |
Other Investing Activities | -0.04 | -0.02 | -0.42 | 3.65 | -0.23 | 1.38 |
Investing Cash Flow | -67.67 | -218.66 | -11.45 | 3.7 | -4.04 | -76.69 |
Short-Term Debt Issued | - | 15 | - | - | - | - |
Total Debt Issued | 15 | 15 | - | - | - | - |
Long-Term Debt Repaid | - | -3.26 | -3.07 | -3.03 | -2.87 | -2.73 |
Net Debt Issued (Repaid) | -3.3 | 11.74 | -3.07 | -3.03 | -2.87 | -2.73 |
Issuance of Common Stock | - | - | 227.69 | - | 13.78 | 164.58 |
Common Dividends Paid | -32.35 | -32.35 | -3.42 | - | - | - |
Financing Cash Flow | -35.65 | -20.61 | 221.2 | -3.03 | 10.91 | 161.85 |
Foreign Exchange Rate Adjustments | -1.3 | 0.36 | 3.41 | -0.11 | 0.55 | -0.77 |
Net Cash Flow | 9.22 | -138.92 | 293.3 | 27.46 | 19.4 | 59.29 |
Free Cash Flow | 97.36 | 81.42 | 77.96 | 21.26 | 7.9 | -28.05 |
Free Cash Flow Growth | 75.81% | 4.44% | 266.69% | 169.26% | - | - |
Free Cash Flow Margin | 30.46% | 26.58% | 34.98% | 13.32% | 7.43% | -49.83% |
Free Cash Flow Per Share | 3.91 | 3.27 | 3.42 | 0.94 | 0.39 | -1.76 |
Cash Interest Paid | 0.13 | 0.13 | 0.18 | 0.22 | 0.15 | 0.21 |
Cash Income Tax Paid | 0.35 | 0.35 | 0.03 | 0.03 | - | - |
Levered Free Cash Flow | 51.59 | 28.82 | 42.3 | 4.93 | 0.88 | -23.28 |
Unlevered Free Cash Flow | 51.66 | 28.9 | 42.41 | 5.07 | 0.97 | -23.15 |
Change in Working Capital | -8.02 | -16.86 | 2.86 | -9 | 1.38 | -2.14 |